论文部分内容阅读
依据癌细胞增殖动力学和腹膜腔给药的药代动力学特点设计了卡铂、5-Fu序贯腔内用药治疗癌性腹水，并用于32例病人治疗，近期疗效较好，总结如下。1临床资料1．1病例选择32例癌性腹水病人，男20例，女12例，年龄25～78岁；其中胃癌8例，肝癌9例，结肠癌l例，胰腺癌2例，胃癌术后
According to the proliferation kinetics of cancer cells and the pharmacokinetic characteristics of peritoneal cavity administration, carboplatin and 5-Fu were used to treat cancerous ascites and used in the treatment of 32 patients. The recent curative effect is good and summarized as follows. 1 Clinical data 1.1 Case selection 32 cases of cancer ascites patients, 20 males and 12 females, aged 25 to 78 years; of which 8 cases of gastric cancer, 9 cases of liver cancer, 1 case of colon cancer, 2 cases of pancreatic cancer, gastric cancer Rear